Enantioseparation of benzazoles and benzanilides on polysaccharide-based chiral columns

Chirality

Volumn 22, Issue 4, 2010, Pages 382-388

  Kubota, Takateru ^a   Sawada, Naotaka ^a   Zhou, Lili ^a   Welch, Christopher J ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Benzanilide; Benzazole; Chiral HPLC; Polysaccharide; Resolution

Indexed keywords

BENZANILIDE DERIVATIVE; BENZAZOLE DERIVATIVE; BENZENE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CHIRAL CHROMATOGRAPHY; CHIRALITY; DRUG DETERMINATION; ENANTIOSELECTIVITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MOLECULAR RECOGNITION; PRIORITY JOURNAL;

AMYLOSE; ANILIDES; BENZOATES; CARBAMATES; CELLULOSE; CHEMISTRY TECHNIQUES, ANALYTICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, ION EXCHANGE; INDOLES; MODELS, CHEMICAL; PHENYLCARBAMATES; POLYSACCHARIDES; STEREOISOMERISM;

EID: 77950392505     PISSN: 08990042     EISSN: 1520636X     Source Type: Journal    
DOI: 10.1002/chir.20732     Document Type: Article

References (28)

1. Stinson SC. Chiral drugs. Chem Eng News 2000;43:55-78.
2. Stinson SC. Chiral chemistry. Chem Eng News 2001;45-57.
3. Thayer AM. Interaction yields. Chem Eng News 2008;12-20.
4. Waldeck B. Biological signi.cance of the enantiomeric purity of drugs. Chirality 1993;5:350-355.
5. Anonymous. FDA's policy statement on the development of new stereoisomeric drugs. Chirality 1992;43:338-340.
6. Pirkle WH, Pochapsky TC. Considerations of chiral recognition relevant to the liquid chromatographic separation of enantiomers. Chem Rev 1989;89:347-362.
7. Chankvetadze B. Chiral separation. Amsterdam: Elsevier; 2001.
8. Okamoto Y, Yashima E. Polysaccharide derivatives for chromatographic separation of enantiomers. Angew Chem Int Ed 1998;37:1020-1043.
9. Yashima E, Yamamoto C, Okamoto Y. Polysaccharide-based chiral LC columns. Synlett 1998;344-360.
10. Yashima E. Polysaccharide-based chiral stationary phases for highperformance liquid chromatographic enantioseparation. J Chromatogr A 2001;906:105-125.
11. Yamamoto C, Okamoto Y. Optically active polymers for chiral separation. Bull Chem Soc Jpn 2004;77:227-257.
12. Theophil E, Siegfried H. The chemistry of heterocycles. Weinheim: Wiley-VCH; 2003.
13. Richardson P, Hawkey CJ, Stack WA. Proton pump inhibitors: pharmacology and rationale for use in gastrointestinal disorders. Drugs 1998;56:307-335.
14. Andersson T, Weidolf L. Stereoselective disposition of proton pump inhibitors. Clin Drug Invest 2008;28:263-279.
15. Unger T. Significance of angiotensin type I receptor blockade: why are angiotensin II receptor blockers different? Am J Cardiol A 1999;84: 9S-15S.
16. Zou B, Yuan Q, Ma D. Synthesis of 1,2-disubstituted benzimidazoles by a Cu-catalyzed cascade aryl amination/condensation process. Angew Chem Int Ed 2007;46:2598-2601.
17. Zheng N, Anderson KW, Huang X, Nguyen HN, Buchwald SL. A palladium-catalyzed regiospecific synthesis of N-aryl benzimidazoles. Angew Chem Int Ed 2007;46:7509-7512.
18. Brändström A, Lindberg P, Junggren U. Structure activity relationships of substituted benzimidazoles. Scand J Gastroenterol 1985; 20(Suppl 108):15-22.
19. Satoh H, Inatomi N, Nagaya H, Inada I, Nohara A, Nakamura N, Maki Y. Antisecretory and antiulcer activities of a novel proton pump inhibitor AG-1749 in dogs and rats. J Pharmacol Exp Ther 1989;248:806-815.
20. McClellan KJ, Goa KL. Candesartan Cilexetil: A review of its use in essential hypertension. Drugs 1998;56:847-869.
21. Shibouta Y, Inada Y, Ojima M, Wada T, Noda M, Sanada T, Kubo K, Kohara Y, Naka T, Nishikawa K. Pharmacological profile of a highly potent and long acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2′-(1H-tetrazol-5-yl) biphenyl-4-yl]methyl]-1H-benzimid azole-7-carboxylic acid (CV-11974), and its prodrug, (±)-1-(cyclohexyloxycarbonyloxy) ethyl 2-ethoxy-1-[[2′- (1H-tetrazol-5-yl)biphenyl-4-y]methyl-11Hbenzimidazole-7-carboxylate (TCV-116). J Pharmacol Exp Ther 1993; 266:114-120.
22. McClellan KJ, Markham A. Telmisartan. Drugs 1998;56:1039-1044.
23. Sharpe M, Jarvis B, Goa KL. Telmisartan: a review of its use in hypertension. Drugs 2001;61:1501-1529.
24. Wienen W, Hauel N, Van Meel JC, Narr B, Ries U, Entzeroth M. Pharmacological characterization of the novel nonpeptide angiotensin II receptor antagonist, BIBR 277. Br J Pharmacol 1993;110:245-252.
25. Itou T, Mase T. A novel practical synthesis of benzothiazoles via Pd-catalyzed thiol cross-coupling. Org Lett 2007;18:3687-3689.
26. Tachibana K, Ohnishi A. Reversed-phase liquid chromatographic separation of enantiomers on polysaccharide type chiral stationary phases. J Chromatogr A 2001;906:127-154.
27. Zhou L, Mao B, Ge Z. Comparative study of immobilized α1 acid glycoprotein and ovomucoid protein stationary phases for the enantiomeric separation of pharmaceutical compounds. J Pharm Bio Anal 2008;46:898-906.
28. Pirkle WH, Welch CJ. Effect of super.uous remote polar functionality on chiral recognition. J Chromatogr A 1992;589:45-51.